Bronchodilator Therapy in Acute Decompensated Heart Failure Patients Without a History of Chronic Obstructive Pulmonary Disease

Annals of Emergency Medicine

Volumn 51, Issue 1, 2008, Pages 25-34

  Singer, Adam J ^a   Emerman, Charles ^b   Char, Douglas M ^c   Heywood, J Thomas ^d   Kirk, J Douglas ^e   Hollander, Judd E ^f   Summers, Richard ^g   Lee, Christopher C ^a   Wynne, Janet ^h   Kellerman, Lois ^h   Peacock, William Frank ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SCRIPPS CLINIC   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^h SCIOS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUTICASONE PROPIONATE PLUS SALMETEROL; GLYCERYL TRINITRATE; IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; LOOP DIURETIC AGENT; PIRBUTEROL; SALBUTAMOL; VASODILATOR AGENT;

ACUTE HEART FAILURE; AGED; AIRWAY PRESSURE; ARTICLE; ARTIFICIAL VENTILATION; CALCULATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMMUNITY HOSPITAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIALYSIS; DRUG USE; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; ENDOTRACHEAL INTUBATION; FEMALE; HISTORY OF MEDICINE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; INTERVENTION STUDY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MONITORING; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REGISTER; RISK; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ACUTE DISEASE; ADMINISTRATION, INHALATION; ADULT; AGED; BRONCHODILATOR AGENTS; DYSPNEA; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 37349101932     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2007.04.005     Document Type: Article

References (17)

1. McCaig L.F., and Burt C.W. National Hospital Ambulatory Medical Care Survey: 2003 emergency department summary. Adv Data 358 (2005) 1-40
2. Abramson M.J., Walters J., and Walters E.H. Adverse effects of beta-agonists: are they clinically relevant?. Am J Respir Med 2 (2003) 287-297
3. Au D.H., Lemaitre R.N., Curtis J.R., et al. The risk of myocardial infarction associated with inhaled beta-adrenoceptor agonists. Am J Respir Crit Care Med 161 (2000) 827-830
4. Au D.H., Udris E.M., Fan V.S., et al. Risk of mortality and heart failure exacerbations associated with inhaled beta-adrenoceptor agonists among patients with known left ventricular systolic dysfunction. Chest 123 (2003) 1964-1969
5. Au D.H., Udris E.M., Curtis J.R., et al. Association between chronic heart failure and inhaled beta-2-adrenoceptor agonists. Am Heart J 148 (2004) 915-920
6. Cazzola M., Matera M.G., and Donner C.F. Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease. Drugs 65 (2005) 1595-1610
7. Coughlin S.S., Metayer C., McCarthy E.P., et al. Respiratory illness, beta-agonists, and risk of idiopathic dilated cardiomyopathy. The Washington, DC, Dilated Cardiomyopathy Study. Am J Epidemiol 142 (1995) 395-403
8. Fisher A.A., Davis M.W., and McGill D.A. Acute myocardial infarction associated with albuterol. Ann Pharmacother 38 (2004) 2045-2049
9. Salpeter S.R., Ormiston T.M., and Salpeter E.E. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest 125 (2004) 2309-2321
10. Adams Jr. K.F., Fonarow G.C., Emerman C.L., et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149 (2005) 209-216
11. D'Agostino Jr. R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
12. Rosenbaum P.R., and Rubin D.B. The central role of the propensity score in observational studies for causal effects. Biometrika 70 (1983) 41-55
13. Rosenbaum P.R., and Rubin D.B. Reducing bias in observational studies using sub-classification on the propensity score. J Am Stat Assoc 79 (1984) 516-524
14. Abraham W.T., Adams K.F., Fonarow G.C., et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol 46 (2005) 57-64
15. Fonarow G.C., Adams Jr. K.F., Abraham W.T., et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 293 (2005) 572-580
16. Seider N., Abinader E.G., and Oliven A. Cardiac arrhythmias after inhaled bronchodilators in patients with COPD and ischemic heart disease. Chest 104 (1993) 1070-1074
17. Sengstock D.M., Obeidat O., Pasnoori V., et al. Asthma, beta-agonists, and development of congestive heart failure: results of the ABCHF study. J Card Fail 8 (2002) 232-238